ENTRY       D11120                      Drug
NAME        Emapalumab (USAN/INN);
            Emapalumab (genetical recombination) (JAN);
            Emapalumab-lzsg;
            Gamifant (TN)
PRODUCT     GAMIFANT (Swedish Orphan Biovitrum AB (publ))
FORMULA     C6430H9898N1718O2038S46
EXACT_MASS  145261.0846
MOL_WEIGHT  145350.6689
SEQUENCE    (Heavy chain)
            EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSA ISGSGGSTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKDG SSGWYVPHWF DPWGQGTLVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS
            REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            NFMLTQPHSV SESPGKTVTI SCTRSSGSIA SNYVQWYQQR PGSSPTTVIY EDNQRPSGVP
            DRFSGSIDSS SNSASLTISG LKTEDEADYY CQSYDGSNRW MFGGGTKLTV LGQPKAAPSV
            TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
            SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
            (Disulfide bridge: H22-H96, H150-H206, H226-L216, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'150-H'206, H'226-L'216, H'267-H'327, H'373-H'431, L22-L91, L139-L198, L'22-L'91, L'139-L'198)
  TYPE      Peptide
REMARK      ATC code: L04AA39
            Product: D11120<US>
EFFICACY    Antineoplastic, Anti-INF-gamma antibody
  DISEASE   Primary hemophagocytic lymphohistiocytosis [DS:H00109]
  TYPE      Monoclonal antibody
COMMENT     Treatment of hemophagocytic lymphohistiocytosis (HLH) and other conditions
TARGET      IFNG [HSA:3458] [KO:K04687]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA39 Emapalumab
                  D11120  Emapalumab (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               Immunological Agents, Miscellaneous
                Emapalumab
                 D11120  Emapalumab (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interferons
                IFNG
                 D11120  Emapalumab (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11120
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11120
DBLINKS     CAS: 1709815-23-5
            PubChem: 376219044
///
